Clinical Trials Browser

Phase 2 × Microsatellite Instability × Ipilimumab × Clear all

NCT03350126 2025-07-23

NIPICOL

Phase 2 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Microsatellite Instability